Cambridge Investment Research Advisors, Inc. Agilon Health, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Agilon Health, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 31,635 shares of AGL stock, worth $52,830. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,635
Previous 36,485
13.29%
Holding current value
$52,830
Previous $239,000
48.12%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AGL
# of Institutions
243Shares Held
400MCall Options Held
2.72MPut Options Held
2.36M-
Clayton, Dubilier & Rice, LLC100MShares$167 Million97.86% of portfolio
-
Morgan Stanley New York, NY56.2MShares$93.9 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA52.9MShares$88.3 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA48.4MShares$80.8 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$51.5 Million0.0% of portfolio
About agilon health, inc.
- Ticker AGL
- Exchange NYSE
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 410,936,000
- Market Cap $686M
- Description
- agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon ...